J&J to cut 400 jobs, 150 in NJ
NEW BRUNSWICK, N.J. (AP) - April 30, 2008 Drug safety problems are being blamed.
The New Brunswick, N.J.-based company is consolidating marketing
and sales departments at its biotechnology businesses.
The company notified employees Tuesday. The company says the
layoffs are in response to falling sales of Procrit - a type of
anemia drug that stimulates formation of red blood cells.
Procrit sales have plunged since federal regulators put new
safety warnings on such drugs last year.
